Search clinical trials for: Insulin resistance

Total 11453 results

University of Pennsylvania
Bayer; National Institutes of Health (NIH)

Completed

Mechanism Based Resistance to Aspirin

Aspirin Resistance | Pharmacological Aspirin Non-responsiveness
Pfizer

Terminated

Long-Term Safety Study Of Inhaled Insulin (CP-464,005, Inhaler) In Japanese Patients With Type1 or Type2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1

Japan
Mannkind Corporation

Completed

To Compare the Effect of Inhaled Insulin With Subcutaneously Injected Insulin in Subjects With Type 2 Diabetes Mellitus.

Diabetes Mellitus, Type 2

Germany
St George's, University of London

Completed

Phase II Study of Safety and Feasibility of Intensive Blood Glucose Control With Insulin on Acute Medical Wards (IPS2008)

Hyperglycemia | COPD

United Kingdom
Mannkind Corporation

Completed

A 3 Month, Randomized, Open Label, Multi-center Study of Technosphere/Insulin Compared to Insulin Aspart in Subjects With Type 1 Diabetes Mellitus Receiving Insulin Glargine

Diabetes Mellitus, Type 1
Federico II University

Completed

Growth Factor/Insulin-like Growth Factor (GH/IGF)-1 Axis in Obese Subjects in Treatment With Orlistat

Obesity
Mannkind Corporation

Completed

Comparison Between Technosphere/Insulin Inhalation Powder Versus Rapid Acting Insulin in Subjects With Type 2 Diabetes Mellitus

Diabetes Type 2

Russian Federation
University of Toronto
Natural Sciences and Engineering Research Council, Canada; Mondelēz International...

Completed

The Effect of Whey Protein and Its Hydrolysate on Pre- and Post-Fixed Meal Glycemia and Insulin in Young Adults

Diabetes Prevention | Obesity Prevention

Canada
The Royal Bournemouth Hospital
Sanofi

Terminated

Insulin Therapy in Chronic Obstructive Pulmonary Disease (COPD) Exacerbations

Hyperglycemia | Chronic Obstructive Pulmonary Disease

United Kingdom
German-Jordanian University
Wyeth is now a wholly owned subsidiary of Pfizer

Unknown

Impact of the 7 Valent Pneumococcal Conjugate Vaccine (7vPCV) on Nasopharyngeal Carriage of Streptococcus Pneumoniae in Healthy Jordanian Infants (7vPCV)

Streptococcus Pneumoniae

Jordan
Royal College of Surgeons, Ireland
Irish Heart Foundation

Completed

Enteric Coating as a Factor in Aspirin Resistance

Cardiovascular Disease

Ireland
Sanofi

Completed

Insulin Glargine Combination Therapies in Type II Diabetics (LAPTOP)

Diabetes Mellitus, Type 2

France, Germany, Netherlands, Spain, Sweden, Switzerland, United Kingdom, Finland, Italy, Austria
Baskent University

Completed

Hyperglycemia in a Coronary Intensive Care Unit

Hyperglycemia | Myocardial Ischemia | Diabetes Mellitus | Blood Glucose

Turkey
Sanofi

Completed

Gulf, Lantus, Apidra Evaluation in Type 1 Diabetics Study (GLANS)

Diabetes Mellitus, Type 1

Bahrain, Kuwait, Qatar, United Arab Emirates
Glostrup University Hospital, Copenhagen

Unknown

Retinal Function in Relation to Long Term Changes in the Glucose Level

Diabetes Mellitus

Denmark
Profil Institut für Stoffwechselforschung GmbH
Emisphere Technologies, Inc.

Completed

Oral Insulin: A Comparison With Subcutaneous Regular Human Insulin in Patients With Type 2 Diabetes

Type 2 Diabetes

Germany
Novartis

Completed

Sandostatin LAR® Depot in Patients With Primary Insulin Hypersecretion (PIH) and at Least Moderate Obesity

Obesity | Primary Insulin Hypersecretion

United States
Sanofi

Completed

Insulin Glulisine, Diabetes Mellitus Type 1

Diabetes Mellitus, Type 1

Russian Federation
University of Cambridge
Cambridge University Hospitals NHS Foundation Trust; Diabetes UK

Completed

Closing the Loop in Adults With Type 1 Diabetes (ANGELA01)

Type 1 Diabetes

United Kingdom
Sanofi

Completed

Insulin Glargine in Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus
Sanofi

Completed

Insulin Glulisine in Diabetes Mellitus, Type 2 (GINGER)

Diabetes Mellitus, Type 2

France, Spain, Italy, Belgium, Germany, Poland, Portugal, Czech Republic, Slovakia, Australia, Netherlands, Sweden, United Kingdom, Switzerland, Romania
Sanofi

Completed

Opposing Step-by-step Insulin Reinforcement to Intensified Strategy (OSIRIS)

Diabetes Mellitus, Type 2

France, Korea, Republic of, Russian Federation, Spain, Italy, Belgium, Germany, Hungary, Ireland, Mexico, Poland, Taiwan, Turkey, Netherlands, Greece, Lithuania, Sweden, United Kingdom
Academisch Medisch Centrum - Universiteit van Amsterdam...
Dutch AIDS Fund

Terminated

Sequential HIV Therapy in Treatment Resistant HIV-1 Infected Patients

HIV Infections

Netherlands
Sanofi

Completed

Insulin Glulisine, Insulin Lispro and Insulin Glargine in Type 1 or 2 Diabetes Mellitus

Diabetes Mellitus

China
Sanofi

Completed

Insulin Glargine in Type 2 Diabetic Patients (TARGET)

Diabetes Mellitus, Type 2

China
Sanofi

Completed

Lantus Versus Levemir Treat-To-Target (L2T3)

Diabetes Mellitus, Type 2

Korea, Republic of, Russian Federation, Spain, Denmark, Canada, Germany, Ireland, Portugal, Australia, India, Turkey, Netherlands, Sweden, United Kingdom, Finland, Switzerland, Romania, Brazil, Serbia, Taiwan
University of Maryland
University of Pittsburgh; University of Maryland School of Medicine

Completed

Gene - Exercise Research Study (GERS)

Cardiovascular Disease Risk Factors

United States
Chinese University of Hong Kong
MetaCure Limited

Unknown

Gastric Modulator (TANTALUS® System) Versus Insulin Treatment in Obese Type 2 Diabetic Patients - a Randomized Control Trial

Type 2 Diabetes Mellitus

China
Association Grenobloise pour le Developpement D...

Unknown

Impact of Functional Insulinotherapy on Blood Glucose Variability Indicators in Patients With Type 1 Diabetes (VARIAFIT)

Type 1 Diabetes

France
John H. Stroger Hospital
Eli Lilly and Company

Completed

Insulin Therapy in the Hospital Comparing Two Protocols

Diabetes Mellitus, Type 2

United States
Profil Institut für Stoffwechselforschung GmbH
Sanofi

Completed

Adjunctive Therapy of Exenatide or Sitagliptin to Insulin Glargine in Type 2 Diabetes

Type 2 Diabetes

Germany
Charite University, Berlin, Germany
Abbott

Completed

Ketoacidosis in Individuals With Type I Diabetes Mellitus (T1DM)

Type 1 Diabetes

Germany
Pfizer

Terminated

A Clinical Trial Comparing Efficacy and Safety of Exubera® and Humalog®

Diabetes Mellitus, Type 1

Denmark, Spain, Sweden, United States, Belgium, Austria, France, Portugal, Ireland, United Kingdom, Finland, Netherlands, Norway
Profil Institut für Stoffwechselforschung GmbH
Sanofi

Completed

Expanded PK and PD of Insulin Glulisine Versus Insulin Aspart in Healthy Volunteers

Diabetes

Germany
Mansoura University

Completed

Combined Metformin and Clomiphene Citrate (CC) or Laparoscopic Ovarian Diathermy for Women With CC Resistant Polycystic Ovary Syndrome (PCOS)

Polycystic Ovary Syndrome

Egypt
Herlev Hospital

Unknown

The Relationship Between the Growth Hormone (GH)- Insulin Like Growth Factor I (IGF-I) System and the Inflammatory System in Healthy Normal Persons

Interaction Between the GH/IGF-I System and the Immune-system

Denmark
Hospital de Clinicas de Porto Alegre
Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul, Brazil; Conselho... and other collaborators

Terminated

Intravenous Insulin in Patients With Diabetes After Percutaneous Coronary Intervention (PCI)

Diabetes Mellitus | Percutaneous Coronary Intervention
Shiraz University of Medical Sciences

Completed

Dose-related Effect of Aspirin on Laboratory-defined Acetylsalicylic Acid Resistance and Clinical Outcome After Coronary Stenting

Coronary Stenting

Iran, Islamic Republic of
Keio University

Completed

Combination of Glinides With Premixed Insulin

Type 2 Diabets Mellitus

Japan
Sanofi

Completed

Efficacy and Safety of Insulin Glulisine in Type 1 Diabetes Mellitus

Diabetes Mellitus, Type 1

Japan
Sanofi

Completed

Efficacy and Safety of Insulin Glulisine in Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2

Japan
University of Virginia
National Institute of Neurological Disorders and Stroke (NINDS)

Completed

Glucose Regulation in Acute Stroke Patients (GRASP) Study

Hyperglycemia | Stroke

United States
Göteborg University
Medical Research Council; Swedish Cancer Foundation

Completed

Insulin Treatment in Cancer Cachexia

Cancer Cachexia

Sweden
Pfizer

Completed

New Antibiotic to Treat Pediatric Patients With Infections Due to a Specific Bacteria (Vancomycin-Resistant Enterococcus)

Bacterial Infections

United States
Hunter Holmes Mcguire Veteran Affairs Medical Center

Unknown

Body Composition Assessment in Spinal Cord Injury

Diabetes Mellitus | Body Composition | Spinal Cord Injury | Tetraplegia | Paraplegia

United States
Mansoura University

Completed

Letrozole or Laparoscopic Ovarian Diathermy for Women With CC Resistant Polycystic Ovary Syndrome.

Polycystic Ovary Syndrome

Egypt
Pfizer
Yale University

Terminated

The Aim is to Estimate the Total Amount of Insulin-producing Cells in the Pancreas by MRI.

Diabetes Mellitus

United States
Glostrup University Hospital, Copenhagen

Completed

Incretin Physiology Associated With Steroid Hormone Treatment

Type 2 Diabetes Mellitus | Steroids

Denmark
Fondazione per la ricerca sulla Fibrosi Cistica

Unknown

Study on the Efficacy of Slow Release Insulin in Cystic Fibrosis Patients With Glucide Intolerance and Clinical Decay

Glucose Intolerance | Cystic Fibrosis

Italy
Assiut University

Completed

Safety Study of Black Cohosh Use by Postmenopausal Women on the Liver (CR-LIVER)

Menopause

Egypt

Search clinical trials for: Insulin resistance

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Serbia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations